

Is Bisoprolol in shortage in 2026? Get the latest update on Bisoprolol availability, why it's hard to find, what it costs, and how to get your prescription filled.
If you've been told your pharmacy is "out of Bisoprolol" or that it's "on backorder," you're probably wondering: Is there a Bisoprolol shortage?
The answer is nuanced. As of early 2026, Bisoprolol is not listed on the FDA's official drug shortage database. That means there isn't a recognized national shortage. However, many patients are still having difficulty filling their prescriptions — and the frustration is very real.
This article breaks down what's actually going on with Bisoprolol availability, what it costs in 2026, and what you can do if your pharmacy can't fill your prescription.
No — not officially. The FDA Drug Shortages Database and the ASHP (American Society of Health-System Pharmacists) shortage list do not currently include Bisoprolol Fumarate.
However, "not in shortage" and "easy to find" are two different things. Bisoprolol falls into a tricky category: it's manufactured and available through distributors, but it's not routinely stocked at many retail pharmacies.
Why? Because in the US, Metoprolol and Atenolol dominate the beta-blocker market. Pharmacies stock what they dispense most frequently, and Bisoprolol prescriptions make up a relatively small share of beta-blocker volume.
Several factors contribute to the difficulty patients experience:
While Bisoprolol is widely used internationally (it's one of the most prescribed beta-blockers in Europe), it's less common in the United States. American prescribing patterns favor Metoprolol Succinate for heart failure and Atenolol for hypertension.
The brand-name version (Zebeta) has been discontinued. Only a handful of generic manufacturers produce Bisoprolol Fumarate for the US market. If one manufacturer has a temporary production issue, availability can become spotty in certain regions.
Chain pharmacies use automated ordering systems that reduce stock of slow-moving items. If a pharmacy dispenses fewer than a few Bisoprolol prescriptions per month, it may drop the drug from its auto-order list entirely.
For the full picture, see our detailed explanation of why Bisoprolol is hard to find in 2026.
Understanding the cost landscape helps you plan:
Without insurance or coupons, a 30-day supply of generic Bisoprolol Fumarate typically costs:
Using free discount cards from GoodRx, SingleCare, or RxSaver, you can often pay:
Generic Bisoprolol is classified as a Tier 1 preferred generic on most insurance formularies, including Medicare Part D plans. Typical copays are $0 to $10 per month.
For a comprehensive guide to reducing your costs, read How to Save Money on Bisoprolol in 2026.
While there are no new Bisoprolol formulations on the market, patients have more ways than ever to access their medication:
If you need Bisoprolol today, here's your action plan:
For detailed strategies, see our complete guide: How to Find Bisoprolol in Stock Near You.
If you've been unable to find Bisoprolol for an extended period and it's affecting your treatment, your doctor may recommend switching to a therapeutic alternative. The most common alternatives include:
Switching should always be done under medical supervision with appropriate dose adjustments.
Bisoprolol is not in a formal shortage in 2026, but that doesn't make it easy to find at every pharmacy counter. The good news is that the drug is available — it's a matter of knowing where to look and planning ahead.
Use Medfinder to check availability, request refills early, and consider mail-order options for a hassle-free supply. If you continue to struggle, your doctor can help you evaluate alternatives that may be easier to access.
Staying on your heart medication matters — don't let a stocking issue become a health issue.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.